Briefly about Anticancer Properties of Statins

Radostina Alexandrova, Desislav Dinev, Milena Glavcheva, Jula Danova, Gunay Yetik-Anacak, Jelena Krasilnikova and Crtomir Podlipnik
Additional contact information
Milena Glavcheva: Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria
Jula Danova: Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria
Gunay Yetik-Anacak: Department of Pharmacology, Faculty of Pharmacy, Ege University, Bornova-Izmir, Turkey
Jelena Krasilnikova: Rigas Stradin University, Riga, Latvia
Crtomir Podlipnik: Faculty of Chemistry and Chemical Technology, University of Lubljana, Lubljana, Slovenia

Biomedical Journal of Scientific & Technical Research, 2019, vol. 17, issue 2, 12655-12659

Abstract: Statins (3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors) have been clinically used for the treatment of dyslipidemia / hypercholesterolemia for almost 40 years...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; 3-Hydroxy-3-Methylglutaryl-CoA (HMG-CoA) Reductase Inhibitors; Statins; Cancer; Antitumor Activity (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.002975.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.002975.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:17:y:2019:i:2:p:12655-12659

DOI: 10.26717/BJSTR.2019.17.002975

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().